Preventive care can transform population health—but too often it stalls between promising ideas and scalable results. Join this panel to explore the Evidence-Based Prevention Continuum, a new framework developed by the Health Care Payment Learning & Action Network (HCPLAN) in partnership with the Center for Medicare and Medicaid Innovation(CMMI) and leaders across health plans, health systems, academia, federal agencies and advocacy organizations.
Panelists will discuss five levels of evidence (from “Opinion-Informed” to “Scaled Evidence-Based”) and will share how preventive interventions fall into different stages on a “Pathway to Scale”—clarifying which payers, funders and mechanisms can advance prevention at each stage. You’ll also learn how quality measures can be used not only for reporting, but also as a strategic lever to pilot emerging interventions and accelerate adoption of those with stronger evidence—while navigating real-world barriers like member churn, lagged outcomes, attribution challenges and budgeting cycles.
Walk away with actionable insights to better measure, fund and scale prevention in ways that improve beneficiary outcomes and align with operational and regulatory realities.
Learning Objectives:
- Understand the five levels of the Evidence-Based Prevention Continuum and how each level maps to specific funding sources and scaling strategies.
- Identify how quality measures can serve as both a pilot tool for interventions with emerging evidence and a scaling mechanism for those with convincing evidence.
- Recognize the market and operational barriers (member churn, lagged outcomes, attribution challenges, budgeting cycles) that impede long-term prevention investment and measurement.
Alice Chen, Centene Corporation
Susannah Bernheim, CMMI
Alex Krist, Virginia Commonwealth University; Inova